Latest filing published 17 Sept 2026 for Travere Therapeutics, Inc., €251k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jula Inrig: trading record in brief
Jula Inrig is a declared insider of Travere Therapeutics, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 1 January 2022 and 15 September 2026, the trades on record add up to 35 filings.
On the market, this insider has only sold: 25 sales, €3.9M in total. Besides market trades, the filings include 7 share grants and 3 option exercises. 2026 to date brings no purchases and 11 sales.
Most recently, on 17 September 2026, the filings show an open-market sale worth €23k in Travere Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jula Inrig
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 32,395 shares@ US$8.930.0046% mcap7.6% of flowCommon StockSEC:0001902368-26-000008:0
- 25,390 shares@ US$62.01670.025% mcap41.4% of flowCommon StockSEC:0001902368-26-000008:1
- 17,284 shares@ US$62.62420.017% mcap28.4% of flowCommon StockSEC:0001902368-26-000008:2
- 1,600 shares@ US$63.6850.0016% mcap2.7% of flowCommon StockSEC:0001902368-26-000008:3
- 400 shares@ US$65.310.0004% mcap0.7% of flowCommon StockSEC:0001902368-26-000008:4
- 14,000 shares0Common StockSEC:0001902368-26-000005:0
- 7,215 shares@ US$41.92880.0054% mcap64.4% of flowCommon StockSEC:0001902368-26-000005:1
- 1,018 shares@ US$42.610.0008% mcap9.2% of flowCommon StockSEC:0001902368-26-000005:2
- 1,547 shares@ US$32.116.6% of flowCommon StockSEC:0001902368-26-000004:0
- 28,130 shares0Common StockSEC:0001902368-26-000003:0
- 2,031 shares@ US$40.1811.0% of flowCommon StockSEC:0001902368-26-000002:0
- 15,000 shares@ US$8.9321.8% of flowCommon StockSEC:0001902368-25-000005:0
- 815 shares@ US$14.652.5% of flowCommon StockSEC:0001415889-25-019108:0
- 8,000 sharesCommon StockSEC:0001415889-25-003819:0
- 30,000 shares0Common StockSEC:0001415889-25-003064:0
- 2,066 shares@ US$19.1036.7% of flowCommon StockSEC:0001415889-25-000899:0
- 684 shares@ US$12.987.7% of flowCommon StockSEC:0001415889-24-023128:0
- 6,750 shares0Common StockSEC:0001415889-24-023093:0
- 25,000 shares0Common StockSEC:0001415889-24-002281:0
- 2,069 shares@ US$9.479417.1% of flowCommon StockSEC:0001209191-24-001005:0
- 20,250 shares0Common StockSEC:0001209191-23-006420:0
- 2,051 shares@ US$20.7538.5% of flowCommon StockSEC:0001209191-23-002325:0
- 20,000 shares0Common StockSEC:0001209191-22-001117:0
23 of 23 declarations
